Correlation Between Oncternal Therapeutics and Scpharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Oncternal Therapeutics and Scpharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncternal Therapeutics and Scpharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncternal Therapeutics and Scpharmaceuticals, you can compare the effects of market volatilities on Oncternal Therapeutics and Scpharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncternal Therapeutics with a short position of Scpharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncternal Therapeutics and Scpharmaceuticals.
Diversification Opportunities for Oncternal Therapeutics and Scpharmaceuticals
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Oncternal and Scpharmaceuticals is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Oncternal Therapeutics and Scpharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scpharmaceuticals and Oncternal Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncternal Therapeutics are associated (or correlated) with Scpharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scpharmaceuticals has no effect on the direction of Oncternal Therapeutics i.e., Oncternal Therapeutics and Scpharmaceuticals go up and down completely randomly.
Pair Corralation between Oncternal Therapeutics and Scpharmaceuticals
Given the investment horizon of 90 days Oncternal Therapeutics is expected to under-perform the Scpharmaceuticals. In addition to that, Oncternal Therapeutics is 2.23 times more volatile than Scpharmaceuticals. It trades about -0.26 of its total potential returns per unit of risk. Scpharmaceuticals is currently generating about -0.23 per unit of volatility. If you would invest 437.00 in Scpharmaceuticals on August 28, 2024 and sell it today you would lose (96.00) from holding Scpharmaceuticals or give up 21.97% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncternal Therapeutics vs. Scpharmaceuticals
Performance |
| Timeline |
| Oncternal Therapeutics |
| Scpharmaceuticals |
Oncternal Therapeutics and Scpharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncternal Therapeutics and Scpharmaceuticals
The main advantage of trading using opposite Oncternal Therapeutics and Scpharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncternal Therapeutics position performs unexpectedly, Scpharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scpharmaceuticals will offset losses from the drop in Scpharmaceuticals' long position.| Oncternal Therapeutics vs. CytomX Therapeutics | Oncternal Therapeutics vs. Assembly Biosciences | Oncternal Therapeutics vs. Instil Bio | Oncternal Therapeutics vs. Nuvation Bio |
| Scpharmaceuticals vs. Capricor Therapeutics | Scpharmaceuticals vs. Soleno Therapeutics | Scpharmaceuticals vs. Bio Path Holdings | Scpharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |